Published in Biochem J on August 15, 1992
Systems analysis of metabolism in the pathogenic trypanosomatid Leishmania major. Mol Syst Biol (2008) 1.49
Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease. Antimicrob Agents Chemother (2010) 1.41
Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug design. J Biol Chem (2004) 1.01
Recent Developments in Drug Discovery for Leishmaniasis and Human African Trypanosomiasis. Chem Rev (2014) 1.00
Improved tricyclic inhibitors of trypanothione reductase by screening and chemical synthesis. ChemMedChem (2009) 0.98
Chemical validation of trypanothione synthetase: a potential drug target for human trypanosomiasis. J Biol Chem (2009) 0.95
Ebsulfur is a benzisothiazolone cytocidal inhibitor targeting the trypanothione reductase of Trypanosoma brucei. J Biol Chem (2013) 0.91
Comparative structural, kinetic and inhibitor studies of Trypanosoma brucei trypanothione reductase with T. cruzi. Mol Biochem Parasitol (2009) 0.90
Thioredoxin reductase and its inhibitors. Curr Protein Pept Sci (2014) 0.89
Parasite-specific trypanothione reductase as a drug target molecule. Parasitol Res (2003) 0.89
Investigation of trypanothione reductase as a drug target in Trypanosoma brucei. ChemMedChem (2009) 0.89
Kukoamine A and other hydrophobic acylpolyamines: potent and selective inhibitors of Crithidia fasciculata trypanothione reductase. Biochem J (1995) 0.87
Dihydroquinazolines as a novel class of Trypanosoma brucei trypanothione reductase inhibitors: discovery, synthesis, and characterization of their binding mode by protein crystallography. J Med Chem (2011) 0.85
Imipramine is an orally active drug against both antimony sensitive and resistant Leishmania donovani clinical isolates in experimental infection. PLoS Negl Trop Dis (2012) 0.84
Trypanothione reductase: a viable chemotherapeutic target for antitrypanosomal and antileishmanial drug design. Drug Target Insights (2007) 0.82
Simple colorimetric trypanothione reductase-based assay for high-throughput screening of drugs against Leishmania intracellular amastigotes. Antimicrob Agents Chemother (2013) 0.80
Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease. Antimicrob Agents Chemother (2016) 0.75
Challenges in the chemotherapy of Chagas disease: Looking for possibilities related to the differences and similarities between the parasite and host. World J Biol Chem (2017) 0.75
Cyclobenzaprine Raises ROS Levels in Leishmania infantum and Reduces Parasite Burden in Infected Mice. PLoS Negl Trop Dis (2017) 0.75
Increasing the activity of copper(II) complexes against Leishmania through lipophilicity and pro-oxidant ability. J Biol Inorg Chem (2011) 0.75
Ketanserin, an antidepressant, exerts its antileishmanial action via inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) enzyme of Leishmania donovani. Parasitol Res (2014) 0.75
The receptor-dependent LQTA-QSAR: application to a set of trypanothione reductase inhibitors. J Comput Aided Mol Des (2012) 0.75
Dataset generated for Dissection of mechanisms of Trypanothione Reductase and Tryparedoxin Peroxidase through dynamic network analysis and simulations in leishmaniasis. Data Brief (2017) 0.75
Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids. Science (1985) 2.94
Refined structure of glutathione reductase at 1.54 A resolution. J Mol Biol (1987) 2.60
Purification and characterization of trypanothione reductase from Crithidia fasciculata, a newly discovered member of the family of disulfide-containing flavoprotein reductases. Biochemistry (1986) 1.62
Fast purification of a functional elongator tRNAmet expressed from a synthetic gene in vivo. Nucleic Acids Res (1988) 1.39
Lethal effect of phenothiazine neuroleptics on the pathogenic protozoan Leishmania donovani. Science (1982) 1.30
Substrate specificity of the flavoprotein trypanothione disulfide reductase from Crithidia fasciculata. Biochemistry (1987) 1.26
Trypanothione reductase from Trypanosoma cruzi. Purification and characterization of the crystalline enzyme. Eur J Biochem (1987) 1.21
Human glutathione reductase: purification of the crystalline enzyme from erythrocytes. Eur J Biochem (1974) 1.16
A crystallographic study of the glutathione binding site of glutathione reductase at 0.3-nm resolution. Eur J Biochem (1989) 1.12
Engineering the substrate specificity of glutathione reductase toward that of trypanothione reduction. Proc Natl Acad Sci U S A (1991) 1.09
Trypanocidal action of neuroleptic phenothiazines in Trypanosoma brucei. Mol Biochem Parasitol (1983) 1.06
Cloning, sequencing, overproduction and purification of trypanothione reductase from Trypanosoma cruzi. Mol Biochem Parasitol (1991) 1.04
Synthesis of N-benzyloxycarbonyl-L-cysteinylglycine 3-dimethylaminopropylamide disulfide: a cheap and convenient new assay for trypanothione reductase. Anal Biochem (1991) 0.99
X-ray structure of trypanothione reductase from Crithidia fasciculata at 2.4-A resolution. Proc Natl Acad Sci U S A (1991) 0.99
Mutational analysis of parasite trypanothione reductase: acquisition of glutathione reductase activity in a triple mutant. Biochemistry (1991) 0.97
Trypanosoma cruzi: possible control of parasite transmission by blood transfusion using amphiphilic cationic drugs. Exp Parasitol (1985) 0.93
Antidepressants cause lethal disruption of membrane function in the human protozoan parasite Leishmania. Science (1984) 0.91
Redox enzyme engineering: conversion of human glutathione reductase into a trypanothione reductase. Biochemistry (1991) 0.88
An assay for screening drugs against animal-infective bloodstream forms of Trypanosoma brucei brucei in vitro. Drugs Exp Clin Res (1985) 0.83
New enzymes for old: redesigning the coenzyme and substrate specificities of glutathione reductase. Bioessays (1991) 0.82
Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids. Science (1985) 2.94
A common structural motif in thiamin pyrophosphate-binding enzymes. FEBS Lett (1989) 2.77
Arsenical-resistant trypanosomes lack an unusual adenosine transporter. Nature (1993) 2.26
Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress. Mol Microbiol (2000) 2.19
Lipoprotein lipase suppression in 3T3-L1 cells by a haematoprotozoan-induced mediator from peritoneal exudate cells. Parasite Immunol (1984) 2.03
In vivo effects of difluoromethylornithine on trypanothione and polyamine levels in bloodstream forms of Trypanosoma brucei. Mol Biochem Parasitol (1987) 1.97
Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen-sensitive and -resistant Trypanosoma brucei brucei. J Biol Chem (1995) 1.80
Purification and characterization of trypanothione reductase from Crithidia fasciculata, a newly discovered member of the family of disulfide-containing flavoprotein reductases. Biochemistry (1986) 1.62
Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages. EMBO J (1997) 1.58
Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs. J Med Chem (1998) 1.55
Trypanothione reductase from Leishmania donovani. Purification, characterisation and inhibition by trivalent antimonials. Eur J Biochem (1995) 1.50
Chondroid tumors of the larynx: computed tomography findings. Am J Otolaryngol (2000) 1.50
Ovothiol and trypanothione as antioxidants in trypanosomatids. Mol Biochem Parasitol (2001) 1.46
The structure of reduced tryparedoxin peroxidase reveals a decamer and insight into reactivity of 2Cys-peroxiredoxins. J Mol Biol (2000) 1.44
Synthesis and cytotoxicity of shikimate analogues. Structure:activity studies based on 1-crotonyloxymethyl-3R,4R,5R-trihydroxycyclohex-2-enone. Anticancer Drug Des (1992) 1.38
A new design of equilibrator to monitor carbon dioxide in highly dynamic and turbid environments. Water Res (2001) 1.35
Mechanism of action of glutathione-dependent enzymes. Adv Enzymol Relat Areas Mol Biol (1987) 1.30
Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors. Structure (1999) 1.28
An improved technique for the cultivation of Plasmodium falciparum in vitro without daily medium change. Ann Trop Med Parasitol (1985) 1.27
Substrate specificity of the flavoprotein trypanothione disulfide reductase from Crithidia fasciculata. Biochemistry (1987) 1.26
The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes. Parasitol Today (1999) 1.26
Increased levels of thiols protect antimony unresponsive Leishmania donovani field isolates against reactive oxygen species generated by trivalent antimony. Parasitology (2007) 1.23
A 7.1 kb linear DNA molecule of Theileria parva has scrambled rDNA sequences and open reading frames for mitochondrially encoded proteins. EMBO J (1994) 1.23
Trypanothione reductase from Trypanosoma cruzi. Purification and characterization of the crystalline enzyme. Eur J Biochem (1987) 1.21
Identification and characterisation of a functional peroxidoxin from Leishmania major. Mol Biochem Parasitol (1998) 1.20
Site-directed mutagenesis of the redox-active cysteines of Trypanosoma cruzi trypanothione reductase. Eur J Biochem (1995) 1.19
Levels of polyamines, glutathione and glutathione-spermidine conjugates during growth of the insect trypanosomatid Crithidia fasciculata. J Gen Microbiol (1988) 1.19
Evidence for gene duplication forming similar binding folds for NAD(P)H and FAD in pyridine nucleotide-dependent flavoenzymes. FEBS Lett (1991) 1.18
Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev (2005) 1.18
Evidence that trypanothione reductase is an essential enzyme in Leishmania by targeted replacement of the tryA gene locus. Mol Microbiol (1998) 1.16
Down-regulation of Leishmania donovani trypanothione reductase by heterologous expression of a trans-dominant mutant homologue: effect on parasite intracellular survival. Proc Natl Acad Sci U S A (1998) 1.14
Trypanothione dependent peroxide metabolism in Crithidia fasciculata and Trypanosoma brucei. Mol Biochem Parasitol (1987) 1.13
Identification of a novel, thiol-containing co-factor essential for glutathione reductase enzyme activity in trypanosomatids. Mol Biochem Parasitol (1985) 1.13
Substrate interactions between trypanothione reductase and N1-glutathionylspermidine disulphide at 0.28-nm resolution. Eur J Biochem (1993) 1.13
Glutathionylspermidine metabolism in Escherichia coli. Biochem J (1995) 1.13
Ornithine decarboxylase gene deletion mutants of Leishmania donovani. J Biol Chem (1999) 1.10
The high resolution crystal structure of recombinant Crithidia fasciculata tryparedoxin-I. J Biol Chem (1999) 1.10
The crystal structure of trypanothione reductase from the human pathogen Trypanosoma cruzi at 2.3 A resolution. Protein Sci (1996) 1.09
"Subversive" substrates for the enzyme trypanothione disulfide reductase: alternative approach to chemotherapy of Chagas disease. Proc Natl Acad Sci U S A (1988) 1.09
Lateral thyrotomy for neurilemmoma of the larynx. J Laryngol Otol (1999) 1.05
Phenotype of recombinant Leishmania donovani and Trypanosoma cruzi which over-express trypanothione reductase. Sensitivity towards agents that are thought to induce oxidative stress. Eur J Biochem (1993) 1.05
Biochemical changes associated with alpha-difluoromethylornithine uptake and resistance in Trypanosoma brucei. Mol Biochem Parasitol (1987) 1.04
Active site of trypanothione reductase. A target for rational drug design. J Mol Biol (1992) 1.02
Surface receptors and transporters of Trypanosoma brucei. Annu Rev Microbiol (1998) 1.02
Characterisation of pentamidine-resistant Trypanosoma brucei brucei. Mol Biochem Parasitol (1995) 1.01
Minor-groove recognition of the self-complementary duplex d(CGCGAATTCGCG)2 by Hoechst 33258: a high-field NMR study. Biochemistry (1990) 1.01
Purification of glutathionylspermidine and trypanothione synthetases from Crithidia fasciculata. Protein Sci (1992) 1.00
Mechanism of inhibition of trypanothione reductase and glutathione reductase by trivalent organic arsenicals. Eur J Biochem (1994) 0.99
Synthesis of N-benzyloxycarbonyl-L-cysteinylglycine 3-dimethylaminopropylamide disulfide: a cheap and convenient new assay for trypanothione reductase. Anal Biochem (1991) 0.99
Fermentation performance and intracellular metabolite patterns in laboratory and industrial xylose-fermenting Saccharomyces cerevisiae. Appl Microbiol Biotechnol (2002) 0.98
Uptake of the trypanocidal drug suramin by bloodstream forms of Trypanosoma brucei and its effect on respiration and growth rate in vivo. Mol Biochem Parasitol (1980) 0.98
Diamine auxotrophy may be a universal feature of Trypanosoma cruzi epimastigotes. Mol Biochem Parasitol (1997) 0.97
Biosynthesis of the trypanosomatid metabolite trypanothione: purification and characterization of trypanothione synthetase from Crithidia fasciculata. Biochemistry (1990) 0.97
Use of an additional hydrophobic binding site, the Z site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazines. J Med Chem (2000) 0.97
Isolation and partial characterization of murine O6-alkylguanine-DNA-alkyltransferase: comparative sequence and structural properties. Mol Carcinog (1992) 0.96
Identification and biosynthesis of N1,N9-bis(glutathionyl)aminopropylcadaverine (homotrypanothione) in Trypanosoma cruzi. Eur J Biochem (1994) 0.96
New approach to screening drugs for activity against African trypanosomes. Nature (1977) 0.96
Botulinum toxin type B for cervical dystonia. Cochrane Database Syst Rev (2005) 0.95
The relationship between income and performance indicators in general practice: a cross-sectional study. Health Serv Manage Res (2005) 0.95
Characterization of protein Ser/Thr phosphatases of the malaria parasite, Plasmodium falciparum: inhibition of the parasitic calcineurin by cyclophilin-cyclosporin complex. Mol Biochem Parasitol (1999) 0.95
Regulation of a high-affinity diamine transport system in Trypanosoma cruzi epimastigotes. Biochem J (1996) 0.94
The biosynthesis of trypanothione and N1-glutathionylspermidine in Crithidia fasciculata. Mol Biochem Parasitol (1986) 0.94
Extrachromosomal, homologous expression of trypanothione reductase and its complementary mRNA in Trypanosoma cruzi. Nucleic Acids Res (1996) 0.94
Role of the N-terminus of glutathione in the action of yeast glyoxalase I. Biochem J (1982) 0.94
Immunoprofile of Hodgkin's lymphoma in India. Indian J Cancer (2008) 0.94
Cloning and sequence analysis of the genes encoding the alpha and beta subunits of the E1 component of the pyruvate dehydrogenase multienzyme complex of Bacillus stearothermophilus. Eur J Biochem (1990) 0.94
Amino acid sequence analysis of the lipoyl and peripheral subunit-binding domains in the lipoate acetyltransferase component of the pyruvate dehydrogenase complex from Bacillus stearothermophilus. Biochem J (1988) 0.94
Rational design of selective ligands for trypanothione reductase from Trypanosoma cruzi. Structural effects on the inhibition by dibenzazepines based on imipramine. J Enzyme Inhib (1997) 0.93
A molecular model for cinnamyl alcohol dehydrogenase, a plant aromatic alcohol dehydrogenase involved in lignification. Biochim Biophys Acta (1993) 0.93
Single-strand cleavage of DNA by Cu(II) and thiols: a powerful chemical DNA-cleaving system. Biochem Biophys Res Commun (1989) 0.92
Transport of ethanolamine and its incorporation into the variant surface glycoprotein of bloodstream forms of Trypanosoma brucei. Mol Biochem Parasitol (1985) 0.92
Expression of genes encoding the E2 and E3 components of the Bacillus stearothermophilus pyruvate dehydrogenase complex and the stoichiometry of subunit interaction in assembly in vitro. Eur J Biochem (1998) 0.92
Cloning and characterization of the two enzymes responsible for trypanothione biosynthesis in Crithidia fasciculata. J Biol Chem (1998) 0.90
Structure of trypanothione reductase from Crithidia fasciculata at 2.6 A resolution; enzyme-NADP interactions at 2.8 A resolution. Acta Crystallogr D Biol Crystallogr (1994) 0.90
Antiprotozoal and cytotoxicity evaluation of sulfonamide and urea analogues of quinacrine. Bioorg Med Chem Lett (2001) 0.90
Characterization of kinetoplast DNA networks from the insect trypanosome Crithidia luciliae. Biochim Biophys Acta (1977) 0.90
Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria. J Med Chem (1998) 0.90
Botulinum toxin type A therapy for hemifacial spasm. Cochrane Database Syst Rev (2005) 0.90
Molecular characterisation of mitochondrial and cytosolic trypanothione-dependent tryparedoxin peroxidases in Trypanosoma brucei. Mol Biochem Parasitol (2001) 0.90
Site-directed mutagenesis of a serine residue in cinnamyl alcohol dehydrogenase, a plant NADPH-dependent dehydrogenase, affects the specificity for the coenzyme. Biochemistry (1995) 0.89
Multiple intestinal malignancy. Clin Oncol (1979) 0.88
Cloning, expression and reconstitution of the trypanothione-dependent peroxidase system of Crithidia fasciculata. Mol Biochem Parasitol (1998) 0.88
Specificity of ethanolamine transport and its further metabolism in Trypanosoma brucei. J Biol Chem (1995) 0.88
Chemical cleavage of plasmid DNA by glutathione in the presence of Cu(II) ions. The Cu(II)-thiol system for DNA strand scission. Biochem J (1991) 0.87
Glutathione derivatives as inhibitors of glutaredoxin and ribonucleotide reductase from Escherichia coli. FEBS Lett (1982) 0.87
Antigenic, microbicidal and antiparasitic properties of an l-amino acid oxidase isolated from Bothrops jararaca snake venom. Toxicon (2008) 0.87
Uptake of the nitroimidazole drug megazol by African trypanosomes. Biochem Pharmacol (2000) 0.87
A photoaffinity label derivative of glutathione and its inhibition of glyoxalase I. FEBS Lett (1980) 0.87
Household bleaches based on sodium hypochlorite: review of acute toxicology and poison control center experience. Food Chem Toxicol (1994) 0.87
An approach to use an unusual adenosine transporter to selectively deliver polyamine analogues to trypanosomes. Bioorg Med Chem Lett (1998) 0.86